57 related articles for article (PubMed ID: 23531280)
1. Selenium promotes immunogenic radiotherapy against cervical cancer metastasis through evoking P53 activation.
Xu Y; Lai H; Pan S; Pan L; Liu T; Yang Z; Chen T; Zhu X
Biomaterials; 2024 Mar; 305():122452. PubMed ID: 38154440
[TBL] [Abstract][Full Text] [Related]
2. Benchmarking of the Cervical Cancer Care Cascade and Survival Outcomes After Radiation Treatment in a Low- and Middle-Income Country Setting.
Grover S; MacDuffie E; Nsingo M; Lei X; Mehta P; Davey S; Urusaro S; Chiyapo S; Vuylsteke P; Monare B; Bazzett-Matabele L; Ralefala T; Luckett R; Ramogola-Masire D; Smith GL
JCO Glob Oncol; 2023 Sep; 9():e2200397. PubMed ID: 37738538
[TBL] [Abstract][Full Text] [Related]
3. The Role of Selenium and Manganese in the Formation, Diagnosis and Treatment of Cervical, Endometrial and Ovarian Cancer.
Golara A; Kozłowski M; Guzik P; Kwiatkowski S; Cymbaluk-Płoska A
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446063
[TBL] [Abstract][Full Text] [Related]
4. Complementary Medicine in the Treatment of Cancer Patients.
Hübner J; Beckmann M; Follmann M; Nothacker M; Prott FJ; Wörmann B;
Dtsch Arztebl Int; 2021 Oct; 118(39):654-659. PubMed ID: 34308831
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Potential of Selenium and Selenium Compounds in Cervical Cancer.
Jablonska E; Li Q; Reszka E; Wieczorek E; Tarhonska K; Wang T
Cancer Control; 2021; 28():10732748211001808. PubMed ID: 33754876
[TBL] [Abstract][Full Text] [Related]
6. [Antioxidants and selenium should not be lumped together into one category-evaluation of supplementation during chemotherapy or radiotherapy for breast cancer].
Piroth MD; Mücke R; Micke O
Strahlenther Onkol; 2019 Sep; 195(9):857-860. PubMed ID: 31263925
[No Abstract] [Full Text] [Related]
7. Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers.
Lawrie TA; Green JT; Beresford M; Wedlake L; Burden S; Davidson SE; Lal S; Henson CC; Andreyev HJN
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012529. PubMed ID: 29360138
[TBL] [Abstract][Full Text] [Related]
8. Micronutrients in Oncological Intervention.
Gröber U; Holzhauer P; Kisters K; Holick MF; Adamietz IA
Nutrients; 2016 Mar; 8(3):163. PubMed ID: 26985904
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Interaction of Antioxidant Supplements as Adjuvant Therapy in Cancer Treatment: A Systematic Review.
Yasueda A; Urushima H; Ito T
Integr Cancer Ther; 2016 Mar; 15(1):17-39. PubMed ID: 26503419
[TBL] [Abstract][Full Text] [Related]
10. Multicenter, phase III trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization.
Muecke R; Micke O; Schomburg L; Glatzel M; Reichl B; Kisters K; Schaefer U; Huebner J; Eich HT; Fakhrian K; Adamietz IA; Buentzel J;
Integr Cancer Ther; 2014 Nov; 13(6):463-7. PubMed ID: 25015649
[TBL] [Abstract][Full Text] [Related]
11. Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology.
Muecke R; Schomburg L; Glatzel M; Berndt-Skorka R; Baaske D; Reichl B; Buentzel J; Kundt G; Prott FJ; Devries A; Stoll G; Kisters K; Bruns F; Schaefer U; Willich N; Micke O;
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):828-35. PubMed ID: 20133068
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant selenium supplementation in the form of sodium selenite in postoperative critically ill patients with severe sepsis.
Sakr Y; Maia VP; Santos C; Stracke J; Zeidan M; Bayer O; Reinhart K
Crit Care; 2014 Apr; 18(2):R68. PubMed ID: 24716537
[TBL] [Abstract][Full Text] [Related]
13. Selenium in Radiation Oncology-15 Years of Experiences in Germany.
Muecke R; Micke O; Schomburg L; Buentzel J; Kisters K; Adamietz IA;
Nutrients; 2018 Apr; 10(4):. PubMed ID: 29652817
[No Abstract] [Full Text] [Related]
14. Selenium in oncology: from chemistry to clinics.
Micke O; Schomburg L; Buentzel J; Kisters K; Muecke R
Molecules; 2009 Oct; 14(10):3975-88. PubMed ID: 19924043
[TBL] [Abstract][Full Text] [Related]
15. Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology--a subgroup analysis of a multicenter, phase III trial.
Muecke R; Micke O; Schomburg L; Buentzel J; Glatzel M; Baaske D; Berndt-Skorka R; Prott FJ; Reichl B; Kisters K; Schaefer U; Huebner J; Eich HT; Kundt G; Adamietz IA
Radiat Oncol; 2013 Mar; 8():72. PubMed ID: 23531280
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
